Malignancy · primary immunosuppression in kidney transplant recipients
Low showed no clear difference in all malignancy compared with higher dose target of rapamycin inhibitor (TOR‐I): primary outcomes (moderate certainty).
1 finding from 1 review
Number needing to change treatment · primary immunosuppression in kidney transplant recipients
Low showed no clear difference in number needing to change treatment compared with higher dose target of rapamycin inhibitor (TOR‐I): primary outcomes (low certainty).
1 finding from 1 review
Diabetes · primary immunosuppression in kidney transplant recipients
Low probably leads to lower diabetes compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (moderate certainty).
1 finding from 1 review
Lymphoma/PTLD · primary immunosuppression in kidney transplant recipients
Low showed no clear difference in lymphoma/PTLD compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (moderate certainty).
1 finding from 1 review
Acne/rash · primary immunosuppression in kidney transplant recipients
Low showed no clear difference in acne/rash compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (low certainty).
1 finding from 1 review
GRF (mL/min) · primary immunosuppression in kidney transplant recipients
1 finding from 1 review
Hypercholesterolaemia · primary immunosuppression in kidney transplant recipients
Low probably leads to lower hypercholesterolaemia compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (moderate certainty).
1 finding from 1 review
Wound complications · primary immunosuppression in kidney transplant recipients
Target of rapamycin inhibitors (TOR‐I) probably leads to higher adverse wound outcomes: all complications compared with calcineurin inhibitors (CNI): main outcomes (moderate certainty).
1 finding from 1 review
Anaemia · primary immunosuppression in kidney transplant recipients
Low may leads to lower anaemia compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (low certainty).
1 finding from 1 review
Thrombocytopenia · primary immunosuppression in kidney transplant recipients
Low may leads to lower thrombocytopenia compared with higher dose target of rapamycin inhibitor (TOR‐ I): secondary outcomes (low certainty).
1 finding from 1 review
All malignancies · primary immunosuppression in kidney transplant recipients
Target of rapamycin inhibitors (TOR‐I) showed no clear difference in all malignancies compared with calcineurin inhibitors (CNI): main outcomes (moderate certainty).
1 finding from 1 review
Number needing to change treatment · primary immunosuppression in kidney transplant recipients
Target of rapamycin inhibitors (TOR‐I) probably leads to higher number needing to change treatment compared with calcineurin inhibitors (CNI): main outcomes (moderate certainty).
1 finding from 1 review
Outcomes (up to 2 years for secondary outcomes) · primary immunosuppression in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Peritonitis · preventing catheter‐related infections in chronic peritoneal dialysis patients
Tenckhoff catheter with artificial curve at tunnel tract showed no clear difference in peritonitis compared with swan‐neck (low certainty).
2 findings from 1 review
Exit‐site/tunnel infection · preventing catheter‐related infections in chronic peritoneal dialysis patients
Tenckhoff catheter with artificial curve at tunnel tract showed no clear difference in exit‐site/tunnel infection compared with swan‐neck (moderate certainty).
2 findings from 1 review
Catheter removal or replacement · preventing catheter‐related infections in chronic peritoneal dialysis patients
Tenckhoff catheter with artificial curve at tunnel tract showed no clear difference in catheter removal or replacement compared with swan‐neck (moderate certainty).
1 finding from 1 review
Technique failure · preventing catheter‐related infections in chronic peritoneal dialysis patients
Tenckhoff catheter with artificial curve at tunnel tract showed no clear difference in technique failure compared with swan‐neck (moderate certainty).
1 finding from 1 review
Death (all causes) · preventing catheter‐related infections in chronic peritoneal dialysis patients
Tenckhoff catheter with artificial curve at tunnel tract showed no clear difference in death (all causes) compared with swan‐neck (low certainty).
1 finding from 1 review
Fracture · preventing bone disease in kidney transplant recipients
Bisphosphonate showed no clear difference in fracture compared with placebo or no treatment (low certainty).
1 finding from 1 review
Death (all causes) · preventing bone disease in kidney transplant recipients
It is very uncertain whether vitamin D changes death (all causes) compared with placebo or no treatment (very low certainty).
1 finding from 1 review